Neurology Clinical Trials Market by Phase (Phase I, Phase II, Phase III, and Phase IV), Study Design (Interventional, Observational, and Expanded Access), Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Amyotrophic Lateral Sclerosis (ALS), Muscle regeneration, and Others), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032

neurology clinical trials market size was $xx million in 2022 and is predicted to grow at a CAGR of xx%, by generating a revenue of $xx million by 2032. Read More